Manufacturers Life Insurance Company, The Astria Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $114 Billion
- Q3 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 14,007 shares of ATXS stock, worth $176,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,007
Previous 16,875
17.0%
Holding current value
$176,067
Previous $90,000
12.22%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ATXS
# of Institutions
121Shares Held
50.8MCall Options Held
48.8KPut Options Held
55.8K-
Perceptive Advisors LLC New York, NY6.49MShares$81.5 Million0.1% of portfolio
-
Vestal Point Capital, LP New York, NY4.96MShares$62.3 Million1.63% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.11MShares$51.6 Million5.98% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$44.7 Million5.59% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$44.2 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $191M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...